An Epstein-Barr virus (EBV) infection — prevalent and spread through bodily fluids — triggered severe immune thrombocytopenia (ITP) and heavy menstrual bleeding in a…
Researchers are developing a potential treatment for immune-mediated thrombotic thrombocytopenic purpura (iTTP) that promotes immune tolerance rather than immunosuppression, according to a study. The approach takes advantage of a naturally occurring process whereby red blood cells deliver small fragments of the ADAMTS13 protein to the immune system, teaching the…
Latest news & perspectives
A real-world study has found that during hospitalizations among people with von Willebrand disease (VWD), VWF replacement therapy with lab-made Veyvondi (vonicog alfa) is…
